相似文献
1
Phenotypes of Psoriasis in Patients in Need of Systemic Treatment, and Correlation with Personal Habits, Treatment History and Comorbidities: A Cross-sectional Latent Class Analysis of Data from the Italian PsoReal Registry.需要全身治疗的银屑病患者的表型及其与个人习惯、治疗史和合并症的相关性：来自意大利PsoReal注册研究数据的横断面潜在类别分析
Acta Derm Venereol. 2023 Apr 4;103:adv5331. doi: 10.2340/actadv.v103.5331.
2
Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).银屑病活动与社会经济地位的相关性：银屑病纵向评估与登记研究（PSOLAR）中入组患者的横断面分析
Br J Dermatol. 2018 Oct;179(4):984-986. doi: 10.1111/bjd.16737. Epub 2018 Jul 20.
3
Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry.一项基于美国大型队列的疾病负担、合并症和治疗使用情况的特征分析：Corrona 银屑病登记处的研究结果。
J Am Acad Dermatol. 2018 Feb;78(2):323-332. doi: 10.1016/j.jaad.2017.10.012. Epub 2017 Oct 16.
4
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry.意大利 Psocare 注册研究：慢性斑块状银屑病患者的潜伏性结核感染证据。
Br J Dermatol. 2015 Jun;172(6):1613-1620. doi: 10.1111/bjd.13539. Epub 2015 Mar 17.
5
Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study.芬兰银屑病患者的合并症和药物使用情况：一项基于人群的登记研究。
Acta Derm Venereol. 2023 Mar 9;103:adv00886. doi: 10.2340/actadv.v103.3491.
6
Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry.中轴型和外周型脊柱关节炎：银屑病是否影响其临床表现和疾病负担？REGISPONSER 登记研究的数据。
Rheumatology (Oxford). 2021 Mar 2;60(3):1125-1136. doi: 10.1093/rheumatology/keaa398.
7
Characterization of Hidradenitis Suppurativa Phenotypes: A Multidimensional Latent Class Analysis of the National Italian Registry IRHIS.化脓性汗腺炎表型特征分析：意大利国家注册研究IRHIS 的多维潜在类别分析。
J Invest Dermatol. 2021 May;141(5):1236-1242.e1. doi: 10.1016/j.jid.2020.08.032. Epub 2020 Oct 21.
8
Establishment of the Western Japan Psoriasis Registry and first cross-sectional analysis of registered patients.日本西部银屑病登记处的建立及登记患者的首次横断面分析。
J Dermatol. 2021 Nov;48(11):1709-1718. doi: 10.1111/1346-8138.16092. Epub 2021 Aug 24.
9
Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry.银屑病全身治疗的联合应用：来自Corrona银屑病登记处的基线特征
J Drugs Dermatol. 2019 Aug 1;18(8):731-740.
10
Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry.从 REGISPONSER 登记处比较银屑病关节炎和强直性脊柱炎伴银屑病患者的轴向表型：一项研究。
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002513.
本文引用的文献
1
Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level.多变量预测模型，以确定个体化治疗银屑病患者的最佳生物疗法。
JAMA Dermatol. 2022 Oct 1;158(10):1149-1156. doi: 10.1001/jamadermatol.2022.3171.
2
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population.对多种生物疗法耐药的银屑病患者：难治性人群的特征与定义
Br J Dermatol. 2022 Aug;187(2):263-265. doi: 10.1111/bjd.21048. Epub 2022 May 24.
3
Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study.红皮病型银屑病患者代谢综合征的患病率：一项病例对照研究。
Front Endocrinol (Lausanne). 2021 Dec 14;12:677912. doi: 10.3389/fendo.2021.677912. eCollection 2021.
4
Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study.体重指数对银屑病患者生物疗法疗效的影响：一项真实世界研究。
Clin Drug Investig. 2021 Oct;41(10):917-925. doi: 10.1007/s40261-021-01080-z. Epub 2021 Sep 18.
5
Patterns of Comorbidities in Psoriasis Patients: A Cross-Sectional Study.银屑病患者的共病模式：一项横断面研究。
Cureus. 2021 May 8;13(5):e14907. doi: 10.7759/cureus.14907.
6
Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab.转换为古塞库单抗后红皮病型银屑病患者的治疗反应
Dermatol Ther (Heidelb). 2021 Feb;11(1):301-306. doi: 10.1007/s13555-020-00480-x. Epub 2021 Feb 3.
7
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations.欧洲皮肤性病学会寻常型银屑病系统治疗指南 - 第1部分：治疗与监测建议
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2461-2498. doi: 10.1111/jdv.16915.
8
Characterization of Hidradenitis Suppurativa Phenotypes: A Multidimensional Latent Class Analysis of the National Italian Registry IRHIS.化脓性汗腺炎表型特征分析：意大利国家注册研究IRHIS 的多维潜在类别分析。
J Invest Dermatol. 2021 May;141(5):1236-1242.e1. doi: 10.1016/j.jid.2020.08.032. Epub 2020 Oct 21.
9
Modeling Heterogeneity in Patients' Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches.在一项多国家研究中对患者对银屑病治疗偏好的异质性建模：随机参数逻辑和潜在类别方法的比较。
Pharmacoeconomics. 2020 Jun;38(6):593-606. doi: 10.1007/s40273-020-00894-7.
10
Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.单皮肤科诊所中红皮病型银屑病中国患者的临床特征及基因多态性
Mol Diagn Ther. 2020 Feb;24(1):85-93. doi: 10.1007/s40291-019-00441-x.
Zotero 插件